A sign at the New York headquarters of pharmaceutical company Pfizer Incorporated.

AstraZeneca Board Rejects New Offer From Pfizer

By
The Associated Press
WNYC News | May 19, 2014

The board of directors of British drug maker AstraZeneca says it rejects the raised $119 billion takeover offer from U.S. drugmaker Pfizer.

In a statement released Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business."

Pfizer Inc., the world's second-biggest drugmaker by revenue, has been courting No. 8 AstraZeneca PLC since January, saying their businesses are complementary and would be stronger together. It said Sunday it was ready to raise its stock-and-cash offer by 15 percent to $118.8 billion, or 70.73 billion pounds.

AstraZeneca's board said it believes Pfizer is making "an opportunistic attempt to acquire a transformed AstraZeneca, without reflecting the value of its exciting pipeline."

Profile Image
The Associated Press

WNYC is funded by sponsors and member donations

WNYC Homepage - Top Stories

NJ Gov. Sherrill: If state police were too aggressive at Delaney Hall, we'll look into it

New Jersey Gov. Mikie Sherrill took call after call Wednesday night from people who told her state police had been overly aggressive in violent clashes with protesters outside the Delaney Hall immigration detention center this weekend.
Ask Governor Sherrill |

I.C.E.'s "Wartime Recruitment" Campaign

Hiring at the highest-funded U.S. law enforcement agency.
On the Media |

Who is ICE detaining at NJ's Delaney Hall? Not as many criminals as DHS suggests.

More than 10,000 people have been detained at the facility. Most have no criminal background.
Gothamist |

Ask the Mayor Recap and More News From City Hall

Elizabeth Kim discusses the issues Mayor Mamdani talked about in his first "ask the mayor" segment.
The Brian Lehrer Show |
YOU ARE ONLINE